Am. J. Respir. Cell Mol. Biol., Volume 20, Number 3, March, 1999 493-499

Bacterial Lipopolysaccharide Induction of the Prostaglandin G/H Synthase 2 Gene Causes Thromboxane-Dependent Pulmonary Hypertension in Rabbits

Peter Delong, M. Gerard O'Sullivan, Edward Huggins, C. L. Hubbard, and Charles McCall

Section on Infectious Diseases, Department of Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina

Two genes encode proteins with prostaglandin G/H synthase (PGHS) activity. PGHS-1 is primarily a constitutively expressed gene, whereas inflammatory agents such as bacterial lipopolysaccharide (LPS) endotoxin rapidly induce the PGHS-2 gene in leukocytes. Both PGHS-1 and PGHS-2 are rate-limiting enzymes for the production of prostaglandins and thromboxane following release of arachidonic acid by phospholipases. We previously reported that LPS perfusion into the circulation of isolated perfused rabbit lung (IPL) results in thromboxane-dependent pulmonary hypertension and lung edema when the LPS-primed lung is subsequently stimulated with platelet activating factor (PAF) (J. Clin. Invest. 1990;85:1135). In this study, we showed that the mechanism by which LPS primes IPL for enhanced production of thromboxane and pulmonary hypertension in response to PAF depends on specific upregulation of the PGHS-2 gene in the rabbit lung. LPS perfusion of IPL induced PGHS-2 gene expression, which correlated with the conversion of free arachidonic acid to thromboxane-B₂ (TXB₂) and the onset of pulmonary hypertension. LPS-induced PGHS-2 expression, TXB₂ release, and pulmonary hypertension were inhibited by actinomycin D (an inhibitor of transcription) and cycloheximide (an inhibitor of protein synthesis). The constitutively expressed PGHS-1 remained unchanged with LPS perfusion, and did not convert free arachidonic acid to TXB₂, suggesting that PGHS-1 does not contribute to the induction of pulmonary hypertension by LPS. These studies reveal a pathogenic role for induction of PGHS-2 in lung injury.

This article has been cited by other articles:

				H. Wahn, J. Wolf, F. Kram, S. Frantz, and J. A. Wagner The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2491 - H2496. [Abstract] [Full Text] [PDF]

				C. Martin, A. Wohlsen, and S. Uhlig Changes in airway resistance by simultaneous exposure to TNF-{alpha} and IL-1{beta} in perfused rat lungs Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L595 - L601. [Abstract] [Full Text] [PDF]

				S. Archer and S. Rich Primary Pulmonary Hypertension : A Vascular Biology and Translational Research "Work in Progress" Circulation, November 28, 2000; 102(22): 2781 - 2791. [Abstract] [Full Text] [PDF]

				H.-D. HELD and S. UHLIG Mechanisms of Endotoxin-Induced Airway and Pulmonary Vascular Hyperreactivity in Mice Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1547 - 1552. [Abstract] [Full Text] [PDF]

				M. Ermert, M. Merkle, R. Mootz, F. Grimminger, W. Seeger, and L. Ermert Endotoxin priming of the cyclooxygenase-2-thromboxane axis in isolated rat lungs Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1195 - L1203. [Abstract] [Full Text] [PDF]

				L. Ermert, M. Ermert, M. Merkle, M. Goppelt-Struebe, H.-R. Duncker, F. Grimminger, and W. Seeger Rat Pulmonary Cyclooxygenase-2 Expression in Response to Endotoxin Challenge : Differential Regulation in the Various Types of Cells in theLung Am. J. Pathol., April 1, 2000; 156(4): 1275 - 1287. [Abstract] [Full Text] [PDF]